← FDA Drug Approvals (Drugs@FDA)

BEXAROTENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2024-12-10

Drug application

FDA Application #

ANDA210352

Application type

Abbreviated New Drug Application (Generic)

Brand name

BEXAROTENE

Generic name

Bexarotene

Active ingredients

BEXAROTENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

CIPLA

First approval

2024-12-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown